Form 8-K - Current report:
SEC Accession No. 0001193125-25-004977
Filing Date
2025-01-13
Accepted
2025-01-13 07:30:52
Documents
54
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917886d8k.htm   iXBRL 8-K 26903
2 EX-99.1 d917886dex991.htm EX-99.1 42937
6 GRAPHIC g917886ex99_1p100g1.jpg GRAPHIC 253211
7 GRAPHIC g917886ex99_1p10g1.jpg GRAPHIC 78592
8 GRAPHIC g917886ex99_1p11g1.jpg GRAPHIC 295704
9 GRAPHIC g917886ex99_1p12g1.jpg GRAPHIC 260916
10 GRAPHIC g917886ex99_1p13g1.jpg GRAPHIC 339376
11 GRAPHIC g917886ex99_1p15g1.jpg GRAPHIC 271579
12 GRAPHIC g917886ex99_1p16g1.jpg GRAPHIC 285959
13 GRAPHIC g917886ex99_1p17g1.jpg GRAPHIC 252249
14 GRAPHIC g917886ex99_1p18g1.jpg GRAPHIC 309319
15 GRAPHIC g917886ex99_1p19g1.jpg GRAPHIC 123023
16 GRAPHIC g917886ex99_1p1g1.jpg GRAPHIC 177456
17 GRAPHIC g917886ex99_1p20g1.jpg GRAPHIC 247786
18 GRAPHIC g917886ex99_1p21g1.jpg GRAPHIC 297657
19 GRAPHIC g917886ex99_1p22g1.jpg GRAPHIC 260491
20 GRAPHIC g917886ex99_1p23g1.jpg GRAPHIC 265477
21 GRAPHIC g917886ex99_1p24g1.jpg GRAPHIC 78691
22 GRAPHIC g917886ex99_1p25g1.jpg GRAPHIC 208524
23 GRAPHIC g917886ex99_1p26g1.jpg GRAPHIC 301011
24 GRAPHIC g917886ex99_1p27g1.jpg GRAPHIC 273039
25 GRAPHIC g917886ex99_1p28g1.jpg GRAPHIC 209768
26 GRAPHIC g917886ex99_1p29g1.jpg GRAPHIC 289128
27 GRAPHIC g917886ex99_1p2g1.jpg GRAPHIC 773267
28 GRAPHIC g917886ex99_1p30g1.jpg GRAPHIC 79741
29 GRAPHIC g917886ex99_1p31g1.jpg GRAPHIC 248663
30 GRAPHIC g917886ex99_1p32g1.jpg GRAPHIC 269182
31 GRAPHIC g917886ex99_1p33g1.jpg GRAPHIC 337373
32 GRAPHIC g917886ex99_1p34g1.jpg GRAPHIC 340785
33 GRAPHIC g917886ex99_1p35g1.jpg GRAPHIC 217483
34 GRAPHIC g917886ex99_1p36g1.jpg GRAPHIC 236021
35 GRAPHIC g917886ex99_1p37g1.jpg GRAPHIC 238252
36 GRAPHIC g917886ex99_1p38g1.jpg GRAPHIC 69867
37 GRAPHIC g917886ex99_1p39g1.jpg GRAPHIC 219463
38 GRAPHIC g917886ex99_1p3g1.jpg GRAPHIC 51739
39 GRAPHIC g917886ex99_1p40g1.jpg GRAPHIC 56101
40 GRAPHIC g917886ex99_1p4g1.jpg GRAPHIC 333787
41 GRAPHIC g917886ex99_1p5g1.jpg GRAPHIC 268323
42 GRAPHIC g917886ex99_1p6g1.jpg GRAPHIC 316983
43 GRAPHIC g917886ex99_1p7g1.jpg GRAPHIC 200449
44 GRAPHIC g917886ex99_1p8g1.jpg GRAPHIC 269964
45 GRAPHIC g917886ex99_1p9g1.jpg GRAPHIC 240983
  Complete submission text file 0001193125-25-004977.txt   13773931

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tngx-20250113.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tngx-20250113_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tngx-20250113_pre.xml EX-101.PRE 11261
56 EXTRACTED XBRL INSTANCE DOCUMENT d917886d8k_htm.xml XML 3636
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 25524811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)